Hua Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hua Liu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Biaoxue Rong
Department of Respiratory Medicine, First Affiliated Hospital, Xi'an Medical University, Xi'an 710077, Shaanxi, China
1 shared publicationChuanYuan Kang
Psychiatry Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China
1 shared publication- Fan Yang
Peoples Hosp Leshan, Dept Gastroenterol, Leshan, Sichuan, Peoples R China
1 shared publication - Guoyuan Qi
University of Arizona, Tucson, AZ USA
1 shared publication - Haoyu Tian
Beijing Jiaotong University
1 shared publication - Hongliang Cong
Department of Cardiology, Tianjin Chest Hospital, Tianjin, China
1 shared publication
Latest Publications
- Open Access
- 1 April 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (4) , 1256-1266
Risk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study
Original Article Risk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study Zesheng Xu, Yingkai Li, Ruyan Zhang, Yongqing Liu, Hua Liu, Jiancai Yu, Xianbo Zhou, Yihui Du, Hongliang Cong
- 1 April 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (4) , 1256-1266
Open AccessRisk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study
Original Article Risk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study Zesheng Xu, Yingkai Li, Ruyan Zhang, Yongqing Liu, Hua Liu, Jiancai Yu, Xianbo Zhou, Yihui Du, Hongliang Cong
- Open Access
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Food Science and Technology
- Vol. 41 (3) , 564-569
A meta-analysis: association between Beta-2 adrenergic receptor Arg16Gly polymorphism and asthma in China
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Food Science and Technology
- Vol. 41 (3) , 564-569
Open AccessA meta-analysis: association between Beta-2 adrenergic receptor Arg16Gly polymorphism and asthma in China
- 25 May 2018
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 9 (6) , 3374-3386
EGCG stimulates the recruitment of brite adipocytes, suppresses adipogenesis and counteracts TNF-α-triggered insulin resistance in adipocytes
The global rise in obesity and type 2 diabetes has precipitated the need for therapeutic intervention in the arsenal against adiposity. (−)-Epigallocatechin-3-gallate (EGCG), a major nutraceutical component of green tea, has been regarded as a nutraceutical that has powerful antioxidant and anti-obesity bioactivities. In the present study, we showed that EGCG alleviates intracellular lipid accumulation markedly, and the inhibitory effect was largely limited to the early stage of adipocyte differentiation. Consistently, EGCG notably evoked the phosphorylation of AMPK and ACC and blunted the key enzymes of de novo lipogenesis. Interestingly, EGCG elicited iWAT-preadipocyte-derived mature white adipocyte beiging via activating thermogenic gene Ucp1 expression and mitochondrial biogenesis. Furthermore, our results also revealed that EGCG attenuated insulin signaling pathway blockage induced by TNF-α through the abrogation of redox imbalance and mitochondrial dysfunction. These findings indicate that EGCG is capable of suppressing adipogenesis and evoking white adipocyte beiging and therefore it may potentially serve as a novel approach to combat obesity.
- 25 May 2018
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 9 (6) , 3374-3386
EGCG stimulates the recruitment of brite adipocytes, suppresses adipogenesis and counteracts TNF-α-triggered insulin resistance in adipocytes
The global rise in obesity and type 2 diabetes has precipitated the need for therapeutic intervention in the arsenal against adiposity. (−)-Epigallocatechin-3-gallate (EGCG), a major nutraceutical component of green tea, has been regarded as a nutraceutical that has powerful antioxidant and anti-obesity bioactivities. In the present study, we showed that EGCG alleviates intracellular lipid accumulation markedly, and the inhibitory effect was largely limited to the early stage of adipocyte differentiation. Consistently, EGCG notably evoked the phosphorylation of AMPK and ACC and blunted the key enzymes of de novo lipogenesis. Interestingly, EGCG elicited iWAT-preadipocyte-derived mature white adipocyte beiging via activating thermogenic gene Ucp1 expression and mitochondrial biogenesis. Furthermore, our results also revealed that EGCG attenuated insulin signaling pathway blockage induced by TNF-α through the abrogation of redox imbalance and mitochondrial dysfunction. These findings indicate that EGCG is capable of suppressing adipogenesis and evoking white adipocyte beiging and therefore it may potentially serve as a novel approach to combat obesity.
- 6 May 2017
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 19 (1) , 35-43
Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer
BACKGROUND: Previous studies show that overexpression of stathmin involved in the malignant biological behavior of lung cancer. This investigation is to disclose the expression status of stathmin in non-small cell lung cancer (NSCLC) and its clinical
- 6 May 2017
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 19 (1) , 35-43
Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer
BACKGROUND: Previous studies show that overexpression of stathmin involved in the malignant biological behavior of lung cancer. This investigation is to disclose the expression status of stathmin in non-small cell lung cancer (NSCLC) and its clinical
- Open Access
- 2 January 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e84414
Association Study of Serotonin Transporter SLC6A4 Gene with Chinese Han Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common clinical gastrointestinal dysfunction disorders. 5-sertonon (5-hydroxytryptamine, 5-HT) is a very important neurotransmitter, which is involved in gastrointestinal motion and sensation. Solute carrier family 6 member 4 (SLC6A4) gene encode serotonin transporter (SERT) which function is to rapidly reuptake the most of 5-HT. Therefore, it is needed to explore the association between SLC6A4 gene polymorphisms and IBS. 119 patients and 238 healthy controls were administrated to detect the SLC6A4 gene polymorphisms including 5-HT-transporter-gene-linked polymorphic region (5-HTTLPR), variable number of tandem repeats (VNTRs) and three selected tag Single Nucleotide Polymorphisms (SNPs) rs1042173, rs3794808, rs2020936 by using polymerase chain reaction (PCR) and TaqMan® SNP Genotyping. There were significant difference for 5-HTTLPR between IBS and control groups (X2 = 106.168, P2 = 50.850, P<0.0001) for 5-HTTLPR. For STin2 VNTR, rs1042173, rs3794808, and rs2020936 polymorphisms, there were no any significant differences between IBS and control groups. There were no statistical significantly haplotypes for 5-HTTLPR, VNTRs and the three SNPs between IBS and controls. The S allele in 5-HTTLPR was a susceptible allele with Chinese Han IBS, but other associations of VNTRs, three selected Tag SNPs and positive haplotype with IBS were not found. It is indicated that much research are needed to study the relationship between other polymorphisms in SLC6A4 gene and IBS.
- 2 January 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e84414
Open AccessAssociation Study of Serotonin Transporter SLC6A4 Gene with Chinese Han Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common clinical gastrointestinal dysfunction disorders. 5-sertonon (5-hydroxytryptamine, 5-HT) is a very important neurotransmitter, which is involved in gastrointestinal motion and sensation. Solute carrier family 6 member 4 (SLC6A4) gene encode serotonin transporter (SERT) which function is to rapidly reuptake the most of 5-HT. Therefore, it is needed to explore the association between SLC6A4 gene polymorphisms and IBS. 119 patients and 238 healthy controls were administrated to detect the SLC6A4 gene polymorphisms including 5-HT-transporter-gene-linked polymorphic region (5-HTTLPR), variable number of tandem repeats (VNTRs) and three selected tag Single Nucleotide Polymorphisms (SNPs) rs1042173, rs3794808, rs2020936 by using polymerase chain reaction (PCR) and TaqMan® SNP Genotyping. There were significant difference for 5-HTTLPR between IBS and control groups (X2 = 106.168, P2 = 50.850, P<0.0001) for 5-HTTLPR. For STin2 VNTR, rs1042173, rs3794808, and rs2020936 polymorphisms, there were no any significant differences between IBS and control groups. There were no statistical significantly haplotypes for 5-HTTLPR, VNTRs and the three SNPs between IBS and controls. The S allele in 5-HTTLPR was a susceptible allele with Chinese Han IBS, but other associations of VNTRs, three selected Tag SNPs and positive haplotype with IBS were not found. It is indicated that much research are needed to study the relationship between other polymorphisms in SLC6A4 gene and IBS.